Log in with your email address username.

×

Important notice

doctorportal Learning is on the move as we will be launching a new website very shortly. If you would like to sign up to dp Learning now to register for CPD learning or to use our CPD tracker, please email support@doctorportal.com.au so we can assist you. If you are already signed up to doctorportal Learning, your login will work in the new site so you can continue to enrol for learning, complete an online module, or access your CPD tracker report.

To access and/or sign up for other resources such as Jobs Board, Bookshop or InSight+, please go to www.mja.com.au, or click the relevant menu item and you will be redirected.

All other doctorportal services, such as Find A Doctor, are no longer available.

Infected jails on Sovaldi frontline

Some of the nation’s most dangerous criminals will be among the first to test Sovaldi’s effectiveness in curing hepatitis C and preventing its transmission.

Hepatitis C is rife in the nation’s prisons, with estimates as many as 50 per cent of inmates are infected – including about two-thirds of female prisoners.

Researchers are recruiting inmates at two New South Wales high-security prisons, Goulburn and Lithgow, to assess the drug’s performance.

Prisoners taking part in the trial will be given one pill a day during a 12-week course of the medicine, which manufacturers claim has a cure rate above 90 per cent.

Prison authorities are grappling with the problem of how to curb the spread of hepatitis C among inmates, who are most commonly infected while injecting illicit drugs using shared contaminated needles.

Public health groups have argued the need for needle and syringe exchange programs within prisons to help slow the spread of hepatitis C, a suggestion vehemently opposed by unions representing prison staff, who claim such measures would make prisons more dangerous.

Liberal MP Steve Irons, who is chairing a House of Representatives committee inquiring into the prevalence of hepatitis C in prisons, said it was an important issue because of the threat of infection in the broader community posed by prisoners as they moved in and out of custody.

Advocates hope Sovaldi could provide an alternative path to breaking the cycle of infection in the nation’s jails.

Adrian Rollins

email